SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008255
Filing Date
2018-11-01
Accepted
2018-11-01 16:03:16
Documents
72
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vvus-20180930x10q.htm 10-Q 2152181
2 EX-10.2 vvus-20180930ex10244b9b4.htm EX-10.2 83676
3 EX-10.3 vvus-20180930ex1031fff39.htm EX-10.3 87951
4 EX-31.1 vvus-20180930ex3118dd144.htm EX-31.1 19926
5 EX-31.2 vvus-20180930ex312da78a6.htm EX-31.2 19761
6 EX-32 vvus-20180930xex32.htm EX-32 16765
  Complete submission text file 0001558370-18-008255.txt   7556042

Data Files

Seq Description Document Type Size
7 EX-101.INS vvus-20180930.xml EX-101.INS 1687425
8 EX-101.SCH vvus-20180930.xsd EX-101.SCH 39921
9 EX-101.CAL vvus-20180930_cal.xml EX-101.CAL 58163
10 EX-101.DEF vvus-20180930_def.xml EX-101.DEF 151379
11 EX-101.LAB vvus-20180930_lab.xml EX-101.LAB 364298
12 EX-101.PRE vvus-20180930_pre.xml EX-101.PRE 294884
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33389 | Film No.: 181153649
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1